Evidence map›Paper›PMID 34820141›Full record

ArticleInternational journal of nephrology2021

Urinary Tract Infections in the First 6 Months after Renal Transplantation.

Ziad Arabi, Khalefa Al Thiab, Abdulrahman Altheaby, Ghaleb Aboalsamh, Samy Kashkoush, Mohamad Almarastani, Mohammed F Shaheen, Abdulrahman Altamimi, Wael O'hali, Khalid Bin Saad and 7 more

Open access · goldAbstract read
In one paragraph

Article in International journal of nephrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Ziad ArabiDivision of Adult Transplant Nephrology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-0514-7389
Khalefa Al ThiabKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abdulrahman AltheabyDivision of Adult Transplant Nephrology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-1832-6706
Ghaleb AboalsamhKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Samy KashkoushKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Mohamad AlmarastaniKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Mohammed F ShaheenKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abdulrahman AltamimiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Wael O'haliKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-3641-315X
Khalid Bin SaadKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Lina AlnajjarDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Rawan AlhusseinCollege of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-9920-5262
Raghad AlmuhitebCollege of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-5402-197X
Bashayr AlqahtaniCollege of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0002-8679-7190
Rayana AlotaibiCollege of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Marah AlqahtaniCollege of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia.
Mohammed TawhariDivision of Adult Transplant Nephrology, King Abdulaziz Medical City, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-3376-0666
King Saud bin Abdulaziz University for Health Sciences · SAPrincess Nourah bint Abdulrahman University · SAKing Abdulaziz Medical City · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeUrinary tract infections (UTIs) are common in the first 6 months after renal transplantation, and there are only limited data about UTIs after transplantation in Saudi Arabia in general.

methodsA retrospective study from January 2017 to May 2020 with 6-month follow-up.

results279 renal transplant recipients were included. Mean age was 43.4 ± 16.0 years, and114 (40.9%) were women. Urinary stents were inserted routinely during transplantation and were removed 35.3 ± 28 days postoperatively. Ninety-seven patients (35%) developed urinary tract infections (UTIs) in the first six months after renal transplantation. Of those who developed the first episode of UTI, the recurrence rates were 57%, 27%, and 14% for having one, two, or three recurrences, respectively. Late urinary stent removals, defined as more than 21 days postoperatively, tended to have more UTIs (OR: 1.43, P: 0.259, CI: 0.76-2.66). Age >40, female gender, history of neurogenic bladder, and transplantation abroad were statistically significant factors associated with UTIs and recurrence. Diabetes, level of immunosuppression, deceased donor renal transplantation, pretransplant residual urine volume, or history of vesicoureteral reflux (VUR) was not associated with a higher incidence of UTIs. UTIs were asymptomatic in 60% but complicated with bacteremia in 6% of the cases. Multidrug resistant organisms (MDROs) were the causative organisms in 42% of cases, and in-hospital treatment was required in about 50% of cases. Norfloxacin + Bactrim DD (160/800 mg) every other day was not associated with the lower risk of developing UTIs compared to the standard prophylaxis daily Bactrim SS (80/400 mg).

conclusionUTIs and recurrence are common in the first 6 months after renal transplantation. Age >40, female gender, neurogenic bladder, and transplantation abroad are associated with the increased risk of UTIs and recurrence. MDROs are common causative organisms, and hospitalization is frequently required. Dual prophylactic antibiotics did not seem to be advantageous over the standard daily Bactrim.

Identifiers

PMID34820141
PMCPMC8608522
OpenAlexW3214595285

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.